Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Godavari Drugs Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹106.00 |
|---|---|
| Day's Range | ₹102.00 - ₹107.00 |
| Open | ₹107.00 |
| 52 Week Range | ₹69.70 - ₹135.25 |
| Volume | 1,691 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1.79 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 26.51 |
| TTM EPS (₹) | 4.04 |
| P/E Ratio | 15.04 |
| Book Value(₹) | 1.54 |
| PAT Margin (%) | 3.86 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 10.13 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 255.03 | 1133.5 |
| Expenses | N/A | N/A |
| PBT | 14.4 | 56.25 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 8.93 | 43.8 |
About Godavari Drugs Ltd.
| Founded | 1987 |
|---|---|
| Managing Director | Mukund Kakani |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,67,630.39 | 1,943.70 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,18,971.76 | 8,265.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,88,358.16 | 4,905.45 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,29,125.81 | 8,910.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,18,915.99 | 1,469.15 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,11,241.63 | 1,117.40 | 835.50 - 835.50 |
| Lupin Ltd. | 1,07,907.43 | 2,242.75 | 1,875.00 - 1,875.00 |
| Max Healthcare Institute Ltd. | 1,04,432.24 | 1,078.50 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,00,729.72 | 2,433.65 | 1,909.70 - 1,909.70 |
| Laurus Labs Ltd. | 1,00,227.92 | 1,857.20 | 810.05 - 810.05 |
No Records Found
Latest News
Jun
23
2026
Posted on Jun 23rd 2026
Godavari Drugs informs about trading window closure
Godavari Drugs has informed that the trading window for dealing in securities of the Company will remain closed for all Designated Persons and their immediate relatives from July 1, 2026 till 48 hours after declaration of the unaudited financial results of the Company for the quarter ending June 30, 2026 by the Company to the Stock Exchange. Accordingly all Connected/ Designated Persons and their relatives have been advised not to trade in the securities of the Company during the aforesaid period of closure of trading window.
The above information is a part of company’s filings submitted to BSE.
Read More
May
20
2026
Posted on May 20th 2026
Godavari Drugs informs about secretarial compliance report
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI’s Master Circular No. HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated 30th January, 2026, Godavari Drugs has informed that it enclosed the Annual Secretarial Compliance Report for the financial year 2025-26. The report will also be available on the Company’s website at www.godavaridrugs.com
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
9
2026
Posted on Aug 9th 2026
Ishita Drugs & Inds. - Quaterly Results
The sales slipped to Rs. 31.45 millions, down -41.76% for the June 2026 quarter as against Rs. 54.00 millions during the year-ago period.The Company's Net profit for the June 2026 quarter have declined marginally to Rs. 2.30 millions as against Rs. 3.03 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 3.55 millions from 4.39 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 31.45 | 54.00 | -41.76 | 31.45 | 54.00 | -41.76 | 146.60 | 149.97 | -2.25 |
| Other Income | 0.36 | 0.91 | -60.44 | 0.36 | 0.91 | -60.44 | 4.73 | 3.36 | 40.77 |
| PBIDT | 3.55 | 4.39 | -19.13 | 3.55 | 4.39 | -19.13 | 12.38 | 13.38 | -7.47 |
| Interest | 0.05 | 0.23 | -78.26 | 0.05 | 0.23 | -78.26 | 0.59 | 0.72 | -18.06 |
| PBDT | 3.50 | 4.16 | -15.87 | 3.50 | 4.16 | -15.87 | 11.79 | 12.66 | -6.87 |
| Depreciation | 0.50 | 0.28 | 78.57 | 0.50 | 0.28 | 78.57 | 1.00 | 1.10 | -9.09 |
| PBT | 3.00 | 3.88 | -22.68 | 3.00 | 3.88 | -22.68 | 10.79 | 11.56 | -6.66 |
| TAX | 0.70 | 0.85 | -17.65 | 0.70 | 0.85 | -17.65 | 3.02 | 2.87 | 5.23 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | -0.08 | -112.50 |
| PAT | 2.30 | 3.03 | -24.09 | 2.30 | 3.03 | -24.09 | 7.77 | 8.69 | -10.59 |
| Equity | 29.90 | 29.90 | 0.00 | 29.90 | 29.90 | 0.00 | 29.90 | 29.90 | 0.00 |
| PBIDTM(%) | 11.29 | 8.13 | 38.85 | 11.29 | 8.13 | 38.85 | 8.44 | 8.92 | -5.35 |
Read More
Aug
9
2026
Posted on Aug 9th 2026
Advanced Enzyme Tech - Quaterly Results
Net sales declined -7.33% to Rs. 1158.57 million from Rs. 1250.24 millions.The Net Profit of the company slipped to Rs. 223.46 millions from Rs. 739.81 millions, a decline of -69.79% on QoQ basis.Operating profit for the quarter ended June 2026 decreased to 326.99 millions as compared to 843.78 millions of corresponding quarter ended June 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 1158.57 | 1250.24 | -7.33 | 1158.57 | 1250.24 | -7.33 | 4527.66 | 3514.11 | 28.84 |
| Other Income | 22.87 | 538.52 | -95.75 | 22.87 | 538.52 | -95.75 | 633.88 | 614.90 | 3.09 |
| PBIDT | 326.99 | 843.78 | -61.25 | 326.99 | 843.78 | -61.25 | 1738.22 | 1321.69 | 31.51 |
| Interest | 0.37 | 0.53 | -30.19 | 0.37 | 0.53 | -30.19 | 2.07 | 2.36 | -12.29 |
| PBDT | 326.62 | 843.25 | -61.27 | 326.62 | 843.25 | -61.27 | 1697.57 | 1319.33 | 28.67 |
| Depreciation | 29.21 | 29.29 | -0.27 | 29.21 | 29.29 | -0.27 | 120.83 | 114.05 | 5.94 |
| PBT | 297.41 | 813.96 | -63.46 | 297.41 | 813.96 | -63.46 | 1576.74 | 1205.28 | 30.82 |
| TAX | 73.95 | 74.15 | -0.27 | 73.95 | 74.15 | -0.27 | 258.68 | 181.08 | 42.85 |
| Deferred Tax | 7.31 | -0.26 | -2911.54 | 7.31 | -0.26 | -2911.54 | -12.01 | 12.22 | -198.28 |
| PAT | 223.46 | 739.81 | -69.79 | 223.46 | 739.81 | -69.79 | 1318.06 | 1024.20 | 28.69 |
| Equity | 223.95 | 223.76 | 0.08 | 223.95 | 223.76 | 0.08 | 223.85 | 223.76 | 0.04 |
| PBIDTM(%) | 28.22 | 67.49 | -58.18 | 28.22 | 67.49 | -58.18 | 38.39 | 37.61 | 2.07 |
Read More
Aug
9
2026
Posted on Aug 9th 2026
Akums Drugs & Pharma - Quaterly Results
The Revenue for the quarter ended June 2026 of Rs. 3922.75 millions grew by 18.00 % from Rs. 3324.43 millions.The Net proft of the company remain more or less same to Rs. 448.39 millions from Rs. 448.67 millions ,decline by -0.06%.Operating profit for the quarter ended June 2026 rose to 746.07 millions as compared to 726.63 millions of corresponding quarter ended June 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 3922.75 | 3324.43 | 18.00 | 3922.75 | 3324.43 | 18.00 | 13487.36 | 13117.84 | 2.82 |
| Other Income | 261.04 | 285.55 | -8.58 | 261.04 | 285.55 | -8.58 | 1129.65 | 1241.92 | -9.04 |
| PBIDT | 746.07 | 726.63 | 2.68 | 746.07 | 726.63 | 2.68 | 2104.25 | 2626.91 | -19.90 |
| Interest | 24.76 | 29.11 | -14.94 | 24.76 | 29.11 | -14.94 | 100.38 | 153.09 | -34.43 |
| PBDT | 721.31 | 697.52 | 3.41 | 721.31 | 697.52 | 3.41 | 1938.68 | 2473.82 | -21.63 |
| Depreciation | 127.95 | 102.46 | 24.88 | 127.95 | 102.46 | 24.88 | 455.03 | 395.45 | 15.07 |
| PBT | 593.36 | 595.06 | -0.29 | 593.36 | 595.06 | -0.29 | 1483.65 | 2078.37 | -28.61 |
| TAX | 144.97 | 146.39 | -0.97 | 144.97 | 146.39 | -0.97 | 367.25 | 468.39 | -21.59 |
| Deferred Tax | -8.53 | -15.84 | -46.15 | -8.53 | -15.84 | -46.15 | -3.69 | -7.14 | -48.32 |
| PAT | 448.39 | 448.67 | -0.06 | 448.39 | 448.67 | -0.06 | 1116.40 | 1609.98 | -30.66 |
| Equity | 306.21 | 306.21 | 0.00 | 306.21 | 306.21 | 0.00 | 306.21 | 306.21 | 0.00 |
| PBIDTM(%) | 19.02 | 21.86 | -12.99 | 19.02 | 21.86 | -12.99 | 15.60 | 20.03 | -22.09 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Godavari Drugs Ltd. is ₹106.00 as of 2026-08-10.
The market capitalisation of Godavari Drugs Ltd. is ₹108.36 as of 2026-08-07.
The 1-year return of Godavari Drugs Ltd. is 23.00% as of 2025-08-08.
The P/E ratio of Godavari Drugs Ltd. is 15.04 as of 2026-08-10.
The 52-week high and low of Godavari Drugs Ltd. are ₹135.25 and ₹69.70, respectively, as of 2026-08-10.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
